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On 24 November 2015, the evidence-based ‘2015 
European guideline on the management of Chlamydia 
trachomatis infections’ was published online [1]. This 
guideline is a comprehensively updated version of the 
2010 European C. trachomatis guideline [2] and pro-
vides up-to-date and detailed guidance regarding the 
testing, diagnosis, treatment and general management 
of C. trachomatis infections in Europe. The important 
updates include, for example:
•	 broader indications for testing and treatment of C. 
trachomatis infections;
•	 clearer recommendation of using exclusively vali-
dated and quality assured highly sensitive and spe-
cific nucleic acid amplification tests for diagnosis;
•	 advice on (repeated) C. trachomatis testing;
•	 recommendations of increased testing particularly at 
sexually transmitted infections and sexual health 
clinics to reduce the incidence of pelvic inflamma-
tory disease and prevent exposure to infection;
•	 recommendations to identify, verify and report C. 
trachomatis variants.
Details are also available in the newly launched guide-
line regarding the aetiology, transmission, clearance, 
epidemiology and taxonomy of C. trachomatis, clinical 
features, recommended diagnostics (including quality 
assurance), advice for C. trachomatis infected patients, 
indications for therapy, recommended and alternative 
treatment regimens for urogenital and extragenital C. 
trachomatis infections, contact tracing and manage-
ment, and the notification of C. trachomatis cases [1]. 
For further details regarding background, evidence 
base of recommendations and discussions, see also 
the published background review for the guideline [3].
C. trachomatis infection, which most frequently is 
asymptomatic, is the most common bacterial sexually 
transmitted infection and a major public health con-
cern globally. In 2012, the World Health Organization 
(WHO) estimated 130.9 million urogenital cases among 
adults worldwide (8.9 million in the WHO European 
region) [4]. In the European Union (EU) and European 
Economic Area (EEA), 384,555 chlamydial cases were 
reported in 26/31 EU/EEA Member States (incidence: 
182 cases per 100,000 population) in 2013. The inci-
dence was higher among females (incidence: 207) than 
in males (incidence: 153) [5]. The true incidence is cer-
tainly significantly higher, due to the asymptomatic 
nature of chlamydial infection, lack of sufficient test-
ing, appropriate diagnostic methods and surveillance 
systems across Europe. For example, 83% of all cases 
were reported in four countries (Denmark, Norway, 
Sweden and the UK). Two thirds of all chlamydial infec-
tions were reported in the 15–24 years age group, with 
the highest incidence among females 20 to 24 years 
of age (incidence: 1,717). Heterosexual transmission 
accounted for 88% of cases. In countries reporting con-
sistently between 2004 and 2013, the overall reporting 
rate has increased by 68%.
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